Skip to main content

All oral evidence

A session is a parliamentary year. Sessions normally begin in the Spring with the State Opening of Parliament and run for about 12 months. There are normally five sessions in each Parliament.

22 July 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Amy Karam (Global Strategist and Fellow at Canadian Global Affairs Institute), Dr Dritan Kaleshi (Head of Technology (5G) at Digital Catapult), and Rt Hon Oliver Dowden MP (Secretary of State for Digital, Culture, Media and Sport at Department for Digital, Culture, Media and Sport)
Committees Science and Technology Committee (Commons)
Oral Evidence
11 November 2020
Inquiry A new UK research funding agency
Witnesses Sir John Kingman (Chair at UK Research and Innovation (UKRI)), Professor Dame Ottoline Leyser (Chief Executive at UK Research and Innovation (UKRI)), Amanda Solloway MP (Minister for Science, Research and Innovation at Department for Business, Energy and Industrial Strategy), and Sarah Hodgetts (Deputy Director for UKRI Sponsorship and Advanced Research Projects Agency at Department for Business, Energy and Industrial Strategy)
Committees Science and Technology Committee (Commons)
Oral Evidence
10 November 2020
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
Oral Evidence
4 November 2020
Inquiry Coronavirus: lessons learnt
Witnesses Professor Peter Horby (Professor of Emerging Infectious Diseases and Global Health at University of Oxford), Professor Andrew Pollard (Trial Chief Investigator at University of Oxford), Professor Robin Shattock (Chair in Mucosal Infection and Immunity at Imperial College London), Professor Wei Shen Lim (Chair, COVID-19 Panel at Joint Committee on Vaccination and Immunisation), and Kate Bingham (Chair at UK Vaccine Taskforce)
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
Oral Evidence
3 November 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Chris Whitty, Chief Medical Officer for England, and Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee (Commons)
Oral Evidence
28 October 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses The Lord Livingston of Parkhead (Chair at Telecoms Diversification Taskforce), Scott Bailey (Deputy Director of the Diversification Unit at Department for Digital, Culture, Media and Sport), Tareq Amin (Chief Technology Officer at Rakuten Mobile), Dr Tobias Feakin (Ambassador for Cyber Affairs and Critical Technology at Australian Government), Dr Ian Levy (Technical Director at National Cyber Security Centre), and Dr Yih-Choung Teh (Group Director for Strategy and Research at Ofcom)
Committees Science and Technology Committee (Commons)
Oral Evidence
21 October 2020
Inquiry Coronavirus: lessons learnt
Witnesses Dr Max Roser (Director at Oxford Martin Programme on Global Development), Professor David Heymann (Professor of Infectious Disease Epidemiology at London School of Hygiene and Tropical Medicine), Professor Mark Woolhouse OBE (Professor of Infectious Disease Epidemiology at University of Edinburgh), Professor John Edmunds OBE (Professor at London School of Hygiene and Tropical Medicine), Sir Ian Diamond (National Statistician at Office of National Statistics), Professor Axel Gandy (Chair in Statistics at Imperial College London), and Dr Clare Gardiner (Director at Joint Biosecurity Centre)
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
Oral Evidence
13 October 2020
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
Oral Evidence
23 September 2020
Inquiry A new UK research funding agency
Witnesses William Bonvillian (Lecturer at Massachusetts Institute of Technology), Dr Peter Highnam (Deputy Director at Defense Advanced Research Projects Agency), Dr Regina Dugan (Chief Executive Officer at Wellcome Leap), and Dr Antoine Petit (Chairman and CEO at French National Centre for Scientific Research (CNRS))
Committees Science and Technology Committee (Commons)
Oral Evidence
7 October 2020
Inquiry A new UK research funding agency
Witnesses Professor Mariana Mazzucato (Chair in the Economics of Innovation and Public Value at University College London), Professor Richard Jones (Chair in Materials Physics and Innovation Policy at University of Manchester), Professor Sir Mark Walport, Former CEO, UK Research and Innovation (2017–2020), and Jo Johnson (Former Minister of State for Universities, Science, Research and Innovation (2016-2018 and July-September 2019) at n/a)
Committees Science and Technology Committee (Commons)
Oral Evidence
30 September 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Ciaran Martin (Professor at University of Oxford), Dr Mike Short (Chief Scientific Adviser at Department for International Trade), Marcus Weldon (President at Bell Labs), Kip Meek (Director at Communications Chambers and the Wireless Infrastructure Group), and Diane Rinaldo (Executive Director at Open RAN Policy Coalition)
Committees Science and Technology Committee (Commons)
Oral Evidence
17 September 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Carl Heneghan (Professor of Evidence-Based Medicine & Director, Centre for Evidence-Based Medicine at University of Oxford), Professor Sylvia Richardson (Director, MRC Biostatistics Unit at Cambridge Institute of Public Health, University of Cambridge), Dr Thomas Waite (Director, Health Protection at Joint Biosecurity Centre), Dr Susan Hopkins (Chief Medical Advisor at NHS Test and Trace), Simon Thompson (Managing Director of the NHS COVID-19 App at NHS Test and Trace), The Baroness Harding of Winscombe (Interim Executive Chair at National Institute for Health Protection), and The Lord Bethell (Parliamentary Under-Secretary of State at Department for Health and Social Care)
Committees Science and Technology Committee (Commons)
Oral Evidence
9 September 2020
Work University research funding (Non-inquiry session)
Witnesses Universities UK, Russell Group, and University of Glasgow
Committees Science and Technology Committee (Commons)
Oral Evidence
22 July 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Amy Karam (Global Strategist and Fellow at Canadian Global Affairs Institute), Dr Dritan Kaleshi (Head of Technology (5G) at Digital Catapult), and Rt Hon Oliver Dowden MP (Secretary of State for Digital, Culture, Media and Sport at Department for Digital, Culture, Media and Sport)
Committees Science and Technology Committee (Commons)
Oral Evidence
21 July 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Rt Hon Matt Hancock MP (Secretary of State for Health and Social Care at Department for Health and Social Care), and Sir Chris Wormald (Permanent Secretary at Department for Health and Social Care)
Committees Science and Technology Committee (Commons)
Oral Evidence
16 July 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee (Commons)
Oral Evidence
9 July 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Dr Yao Wenbing (Vice President Business Development and Partnerships at Huawei UK), Mr Jeremy Thompson (Vice President at Huawei UK), Victor Zhang (Vice President and Chief Representative at Huawei UK), Woojune Kim (Executive Vice President at Samsung), Andrea Dona (Head of Networks at Vodafone UK), and Howard Watson (Chief Technology and Information Officer at BT Group)
Committees Science and Technology Committee (Commons)
Oral Evidence
1 July 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Sarah Gilbert (Professor of Vaccinology at University of Oxford), Kate Bingham (Chair at UK Government Vaccine Taskforce), Professor Sir John Bell (Regius Professor of Medicine at University of Oxford), Professor Jonathan Van-Tam (Deputy Chief Medical Officer and Lead, Therapeutics Taskforce at Department for Health and Social Care), and Dr Jonathan Sheffield (Covid-19 Research Operations Director at National Institute for Health Research)
Committees Science and Technology Committee (Commons)
Oral Evidence
24 June 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Matthew Evans (Director (Markets) at techUK), Professor Dimitra Simeonidou (Professor of High Performance Networks at University of Bristol), and Attilio Zani (Executive Director at Telecom Infra Project)
Committees Science and Technology Committee (Commons)
Oral Evidence
10 June 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Mark Woolhouse OBE (Professor of Infectious Disease Epidemiology at University of Edinburgh), Professor Johan Giesecke (Former State Epidemiologist for Sweden and Professor Emeritus at Karolinska Institute), Professor Neil Ferguson OBE (Professor of Mathematical Biology at Imperial College London), Professor Matt Keeling (Professor of Mathematics and Life Sciences at University of Warwick), and Dr Nicholas Davies (Research Fellow in Mathematical Modelling at London School of Hygiene and Tropical Medicine)
Committees Science and Technology Committee (Commons)
Oral Evidence
Total results 32 (page 1 of 2)